Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Items 801–900 of 1,000
Hosseini, S. N., Ghodousi, A., Sadeghi, N., & Abbasi, S. (2019) · International Journal of Medical Toxicology and Forensic Medicine · doi:10.32598/ijmtfm.v9i4.26184 · Cited by 1
Compassionate Care of the Patient Who Uses Substances: Implications for the Infusion Nurse
Knapp, M., & Gilles, S. (2020) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000359 · Cited by 1
Chapter 36. Substance-Related Disorders in Women
Hennessy, G., Guille, C., & Greenfield, S. F. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb36 · Cited by 1
Samiee‐Zafarghandy, S., van Donge, T., Allegaert, K., & van den Anker, J. N. (2021) · Children · doi:10.3390/children8030174 · Cited by 1
Galvin, S. L., & Ramage, M. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000904 · Cited by 1
Spezielle Arzneimitteltherapie in der Schwangerschaft
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-21203-1.10002-0 · Cited by 1
(2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571 · Cited by 1
Global research production in neonatal abstinence syndrome: A bibliometric analysis
Zyoud, S. H., Al‐Jabi, S. W., Shahwan, M. J., & Jairoun, A. A. (2022) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v11.i3.308 · Cited by 1
Baysinger, C. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-59680-8_114 · Cited by 1
Neurotransmitters and Drug Abuse
Kaufman, D. M., Geyer, H. L., Milstein, M. J., & Rosengard, J. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-79680-4.00021-8 · Cited by 1
Opioids and Opiates: Pharmacology, Abuse, and Addiction
Cruz, S. L., & Granados‐Soto, V. (2021) · Springer eBooks · doi:10.1007/978-1-4614-6434-1_156-2 · Cited by 1
Brewer, S. K., Davis, J. M., Singh, R., & Welch, L. C. (2022) · Journal of Clinical and Translational Science · doi:10.1017/cts.2022.431 · Cited by 1
Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
Tavakoli, A., Donovan, K., Sweeney, H., Uquillas, K. R., & Gordon, B. J. (2023) · Cureus · doi:10.7759/cureus.36376 · Cited by 1
Kelly, J. C., Ayala, N. K., Holroyd, L. E., Raghuraman, N., Carter, E. B., Williams, S. A. S., Mills, M., Friedman, H., Zhang, F., & Townsel, C. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.100998 · Cited by 1
Sulashvili, N., Abuladze, N. B., Beglaryan, M., Cheishvili, J., Tadevosyan, A., & Sulashvil, M. (2023) · ScienceRise Biological Science · doi:10.15587/2519-8025.2023.276374 · Cited by 1
Turner, S., Allen, V. M., Carson, G., Graves, L. E., Tanguay, R. L., Green, C. R., & Cook, J. L. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.05.014 · Cited by 1
Treatments for Substance Use Disorders
da Costa, S. C., Moustafa, Y., Vasquez, A., & Rummans, T. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00047-6 · Cited by 1
Bedrick, B. S., Cary, C. B., O'Donnell, C., Marx, C. M., Friedman, H., Carter, E. B., Raghuraman, N., Stout, M. J., Ku, B. S., Xu, K. Y., et al. (2024) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2024.100218 · Cited by 1
Gestational buprenorphine-naloxone exposure and fetal neurobehavior
Jansson, L. M., McConnell, K., Vélez, M. L., Spencer, N., Milio, L. A., Leoutsakos, J., & DiPietro, J. A. (2024) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2024.107368 · Cited by 1
Opioid Agonists and Perioperative Management of Patients on Maintenance Therapy
Boss, S., Bielawiec, T., Gwede, M., Ram, B. S., & Elmofty, D. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-67648-2_21 · Cited by 1
(2024) · Journal of Women’s Health Care and Management · doi:10.47275/2692-0948-161 · Cited by 1
М'ясоєдов, В. В. (. В. Р. )., Єрмоленко, Т. І., & Шаповал, О. М. (2023) · Kharkiv National Medical University Repository (Kharkiv National Medical University) · Cited by 1
The Complex Factors Determining Neonatal Abstinence Syndrome and Its Management
Newman, R. G., & Gevertz, S. G. (2012) · European Addiction Research · doi:10.1159/000341994 · Cited by 1
Bart, G. B. (2013) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
IBriS study : intervention supporting breastfeeding in substance dependency
MacVicar, S. (2016) · Edinburgh Napier Research Repository (Edinburgh Napier University) · Cited by 1
Liao, M. Z. (2018) · ResearchWorks at the University of Washington (University of Washington) · Cited by 1
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0001 · Cited by 1
Fareed, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398338-1.00043-9 · Cited by 1
Addictions and Substance Misuse
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg004 · Cited by 1
Morgan, J. R., & Leech, A. A. (2024) · Addiction · doi:10.1111/add.16495 · Cited by 1
Assessment of nutritional status in pregnant women on opioid maintenance therapy
Shrestha, S. (2015) · UNM’s Digital Repository (University of New Mexico)
Newman, R. G., & Gevertz, S. G. (2014) · Europe PMC (PubMed Central)
Substance Abuse: Opioid‐Related Disorders
WOODY, G. E., & Fudala, P. J. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch78
Evidence-based pharmacotherapy of illicit substance use disorders
van den Brink, W. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.013
A Reexamination of US Heroin Policy
Fogel, D. S. (2011) · Scholarship - Claremont (Claremont Colleges)
Special population: Pregnancy, pain and addiction
Taylor, D. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-08111-3_5
A Relevant Comparison Between Buprenorphine And Methadone in Various Aspects
Qidwai, K. (2015) · UNM’s Digital Repository (University of New Mexico)
Sécurité de la plus récente classe d’antagonistes des opioïdes durant la grossesse
Poon, S., Pupco, A., Koren, G., & Bozzo, P. (2014) · PubMed Central
Use of DonnatalTM Elixir in the Treatment of Neonatal Abstinence Syndrome
Brzenski, A. B., & Greenberg, M. (2014) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/12419
Recent Publications on Medications and Pharmacy
Russett, F. (2012) · Hospital Pharmacy · doi:10.1310/hpj4705-401
Current Status and Future Diagnostic Trends of Prenatal Illicit Drug Exposure in the Neonate
Yang, S. (2012) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2012.01.003
Response to Comments by Hendrée Jones et al.
Newman, R. G., & Gevertz, S. G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.736272
Neonatal Abstinence Syndrome: Is Buprenorphine Better?
Kanto, W. P. (2010) · Journal watch · doi:10.1056/pa201012220000001
Pharmacogenomic Predictors of Neonatal Abstinence Syndrome: Correlation With Length of Stay
Kelly, L. E., Knoppert, D., & Koren, G. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000147
Chapter 50. Opioid-Related Disorders: Agonist Maintenance Treatment
Schottenfeld, R. S., & Marienfeld, C. B. (2014) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585625048.gg50
Office care of substance abuse patients
Dresang, L., Brown, R., & Kvach, E. J. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316084380.046
Chapter 48. Opioid-Related Disorders: Opioid Detoxification
Kelly, M. A., & Kleber, H. D. (2014) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585625048.gg48
(2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316084380.035
Ferreira, C. C. R., Moreira, M. V. G., Herculano, R. D. A. N., & Silva, S. A. B. (2016) · Revista de Medicina · doi:10.11606/issn.1679-9836.v95i2p71-75
The relationship between methylation and genes associated with opioid response in humans
McLaughlin, P. A. (2016) · Bournemouth University Research Online (Bournemouth University)
Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome
Mactier, H. (2017) · Addiction · doi:10.1111/add.13735
Stabler, M. E. (2015) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6711
Laird, M. K. (2016) · UC Research Repository (University of Canterbury) · doi:10.26021/8440
AN ANALYSIS OF A MULTIVALENT HEROIN AND PRESCRIPTION OPIOID VACCINE
Louderback, H. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Buprenorphine and Naloxone Compared With Methadone Treatment in Pregnancy
Wiegand, S. L., Stringer, E. M., Stuebe, A. M., Jones, H. E., Seashore, C. J., & Thorp, J. M. (2015) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000472710.26833.08
Self-citationUnderstanding the Agent, Part III: Specific Drugs
McAnally, H. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-47497-7_4
Raughley, M. J., & LaMonica, G. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.040
Cesarean Delivery Complications and Cesarean Hysterectomy
Altizer, M. D. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.009
Dermatologic Disorders and Pregnancy
Stockdale, C. K., & Martini, S. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.046
Lemon, L. S. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Akinlaja, O. A., & Gist, W. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.032
Management of Obstetric Umbilical Cord Complications
Bressman, P. L. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.006
Elson, M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.047
The Obstetric Patient with Trauma
Plaat, F., & Cox, C. W. F. M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.031
Petruska, S. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.010
Diabetes Mellitus in Pregnancy
Hamdi, M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.044
Hematologic Diseases Complicating Pregnancy
Bowersox, N. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.041
Neurological Disease Complicating Pregnancy
Antoniewicz, L. W., & Schneider, K. M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.039
Richard, S. D., & Veselis, C. A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.051
Thromboembolic Complications of Pregnancy
Kuhlmann, Z. C. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.052
Pulmonary Disease in Pregnancy
Shumway, J. B., & Babarinsa, I. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.038
Psychiatric Diseases in Pregnancy and the Postpartum Period
Hoffman, M. C., & Hamalian, G. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.049
Rebele, E. C. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.027
Connective Tissue Disorders and Pregnancy
Peterson, J. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.045
Human Immunodeficiency Virus Infection and Pregnancy
Willers, D. M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.048
Obstetric Ultrasound for the Generalist Obstetrician
Rotholz, S., & Galan, H. L. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.015
Ladson, G. M., Looney, K. R., & Jackson, S. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.053
Alloimmunization and Non-immune Hydrops Fetalis
Goodnight, W., & OLSEN, M. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.019
Perineal Trauma after Vaginal Delivery: Third and Fourth Degree Lacerations and Hematomas
Martinez, A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.012
Premature Rupture of Fetal Membranes Preterm and at Term
Lagow, J. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.024
Leftwich, H. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.018
TRAJETÓRIAS DE PESQUISA: o grupo COMPASSODF e a História Cultural
de Souza, M. M., de Carvalho, R. P. F., Batista, C. O., & dos Santos, E. S. C. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Terplan, M. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780190265366.003.0032
Therapieempfehlungen für opiatkonsumierende Schwangere
Siedentopf, J.-P. (2017) · doi:10.1007/978-3-89935-307-5_4
Rice, J. (2018) · UKnowledge (University of Kentucky)
Substances psychoactives, licites et illicites
Dayan, J., Andro, G., Dugnat, M., Thessier, N., Milijkovitch, R., & Rosenblum, O. (2014) · Elsevier eBooks · doi:10.1016/b978-2-294-71024-7.00014-1
DeBenedetto, R., & Luttrell, S. E. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.opioid-use_overview
Scott, L. A. (2018) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1309
Methadone or buprenorphine? The choice of substitution therapy in pregnant opioid dependent women
Zalewska-Kaszubska, J. (2018) · Alcoholism and Drug Addiction · doi:10.5114/ain.2018.81301
Connect the Dots—November 2016
Miller, L. A., Chen, M. J., Eke, A. C., & Chescheir, N. C. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001732
Weight Management Toolkit for Patients on Methadone
Olugboja, B. (2019) · ScholarWorks (Walden University)
Perceptions of Emergency Room Nurses Regarding Needle Exchange Programs
Murray, T. (2019) · DigitalCommons (California Polytechnic State University)
Apelt, S. M. (2019) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.23930
Prenatal methadone exposure and the developing brain
Monnelly, V. J. (2019) · ERA
Sherehiy, M. (2019) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3196
Melbostad, H. S. (2019) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
Causes of Substance Use Disorders
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0003
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.